Moreover, p38 transgenic mice also display attenuation of astrocyte migration and astrogliosis, which attenuate the overall damage induced by an ischaemic stroke.[113] As such, p38 seems to play a negative role in an ischaemic stroke and is therefore a potential post-stroke therapeutic target. The gene discussed is MAPK1; the disease is stroke disorder.